As of April 2024 Sage Therapeutics has a market cap of $0.82 Billion. This makes Sage Therapeutics the world's 5346th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.82 B | -36.67% |
2023 | $1.30 B | -42.67% |
2022 | $2.26 B | -9.45% |
2021 | $2.50 B | -50.3% |
2020 | $5.04 B | 34.64% |
2019 | $3.74 B | -16.62% |
2018 | $4.49 B | -34.44% |
2017 | $6.85 B | 261.02% |
2016 | $1.89 B | 12.93% |
2015 | $1.68 B | 79.19% |
2014 | $0.93 B |
On Apr 27th, 2024 the market cap of Sage Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Regulus Therapeutics RGLS | $0.15 B | -80.77% | ๐บ๐ธ USA |
Intercept Pharmaceuticals
ICPT | $0.79 B | -3.54% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | $26.63 B | 3,132.48% | ๐ฎ๐ช Ireland |
Eagle Pharmaceuticals
EGRX | $53.9 M | -93.46% | ๐บ๐ธ USA |